GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 07:45 |
GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une…
|
French | 204.9 KB | ||
| 2025-11-10 07:45 |
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Rege…
|
English | 223.5 KB | ||
| 2025-11-10 07:30 |
GENFIT présente de nouvelles données précliniques prometteuses sur NTZ/G1090N d…
|
French | 315.9 KB | ||
| 2025-11-10 07:30 |
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment …
|
English | 217.0 KB | ||
| 2025-09-22 22:00 |
Attestation de la personne responsable associée au rapport d'activité et financ…
|
French | 118.9 KB | ||
| 2025-06-17 20:30 |
GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025
|
French | 140.4 KB | ||
| 2025-06-17 20:30 |
GENFIT: June 17, 2025 Combined Shareholders Meeting Results
|
English | 140.0 KB | ||
| 2025-05-22 22:10 |
GENFIT Reports First Quarter 2025 Financial Information
|
English | 163.4 KB | ||
| 2025-05-22 22:10 |
GENFIT : Information financière du premier trimestre 2025
|
French | 146.7 KB | ||
| 2025-05-20 22:10 |
GENFIT to receive a €26.5 million milestone payment following the approval of p…
|
English | 143.6 KB | ||
| 2025-05-20 22:10 |
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l…
|
French | 137.3 KB | ||
| 2025-05-14 22:10 |
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year…
|
English | 793.3 KB | ||
| 2025-05-07 22:10 |
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposi…
|
French | 129.1 KB | ||
| 2025-05-07 22:10 |
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Prepa…
|
English | 135.6 KB | ||
| 2025-05-05 07:30 |
GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
|
French | 228.8 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
